Botulinum toxin injection in epicardial autonomic ganglia temporarily suppresses vagally mediated atrial fibrillation

Circulation: Arrhythmia and Electrophysiology

Volumn 4, Issue 4, 2011, Pages 560-565

  Oh, Seil ^a   Choi, Eue Keun ^a   Zhang, Youhua ^b   Mazgalev, Todor N ^b  

^a Seoul National University College of Medicine   (South Korea)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atrial fibrillation; Autonomic nerve; Botulinum toxin

Indexed keywords

BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC GANGLION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFECT; EPICARDIUM; EXPERIMENTAL DOG; FOOT PAD; GANGLION BLOCK; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE REFRACTORY PERIOD; INFRAPATELLAR FAT BODY; MALE; NERVE BLOCK; NONHUMAN; PRIORITY JOURNAL; SINUS NODE; VAGUS NERVE STIMULATION; ANIMAL; DISEASE MODEL; DOG; ELECTROSTIMULATION; HEART FUNCTION TEST; INJECTION; INNERVATION; PATHOPHYSIOLOGY; PERICARDIUM; PHYSIOLOGY; REFRACTORY PERIOD; TIME; TREATMENT OUTCOME; VAGUS NERVE;

ANIMALS; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; BOTULINUM TOXINS; CHOLINERGIC ANTAGONISTS; DISEASE MODELS, ANIMAL; DOGS; ELECTRIC STIMULATION; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; GANGLIA, AUTONOMIC; INJECTIONS; MALE; PERICARDIUM; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; SINOATRIAL NODE; TIME FACTORS; TREATMENT OUTCOME; VAGUS NERVE;

EID: 80054017038     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.111.961854     Document Type: Article

References (22)

1. Ardell JL, Randall WC, Cannon WJ, Schmacht DC, Tasdemiroglu E. Differential sympathetic regulation of automatic, conductile, and contractile tissue in dog heart. Am J Physiol. 1988;255:H1050-H1059.
2. Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes: the third fat pad. Circulation. 1997;95: 2573-2584. (Pubitemid 27233124)
3. Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247:289-298. (Pubitemid 27053904)
4. Pauza DH, Skripka V, Pauziene N, Stropus R. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec. 2000;259:353-382. (Pubitemid 30640805)
5. Schauerte P, Scherlag BJ, Pitha J, Scherlag MA, Reynolds D, Lazzara R, Jackman WM. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation. 2000;102:2774-2780.
6. Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, Mazzone P, Tortoriello V, Landoni G, Zangrillo A, Lang C, Tomita T, Mesas C, Mastella E, Alfieri O. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation. 2004;109:327-334. (Pubitemid 38133899)
7. Lemery R, Birnie D, Tang AS, Green M, Gollob M. Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation. Heart Rhythm. 2006;3:387-396.
8. Edgerton JR, Jackman WM, Mack MJ. Minimally invasive pulmonary vein isolation and partial autonomic denervation for surgical treatment of atrial fibrillation. J Interv Card Electrophysiol. 2007;20:89-93.
9. Oh S, Zhang Y, Bibevski S, Marrouche NF, Natale A, Mazgalev TN. Vagal denervation and atrial fibrillation inducibility: epicardial fat pad ablation does not have long-term effects. Heart Rhythm. 2006;3:701-708.
10. Montecucco C, Schiavo G, Tugnoli V, de Grandis D. Botulinum neurotoxins: mechanism of action and therapeutic applications. Mol Med Today. 1996;2:418-424. (Pubitemid 126376940)
11. Rossetto O, Seveso M, Caccin P, Schiavo G, Montecucco C. Tetanus and botulinum neurotoxins: turning bad guys into good by research. Toxicon. 2001;39:27-41. (Pubitemid 30628927)
12. Tsuboi M, Furukawa Y, Kurogouchi F, Nakajima K, Hirose M, Chiba S. Botulinum neurotoxin a blocks cholinergic ganglionic neurotransmission in the dog heart. Jpn J Pharmacol. 2002;89:249-254.
13. Oh S, Choi EK, Choi YS. Short-term autonomic denervation of the atria using botulinum toxin. Korean Circ J. 2010;40:387-390.
14. Zhang Y, Ilsar I, Sabbah HN, Ben David T, Mazgalev TN. Relationship between right cervical vagus nerve stimulation and atrial fibrillation inducibility: therapeutic intensities do not increase arrhythmogenesis. Heart Rhythm. 2009;6:244-250.
15. Kneller J, Zou R, Vigmond EJ, Wang Z, Leon LJ, Nattel S. Cholinergic atrial fibrillation in a computer model of a two-dimensional sheet of canine atrial cells with realistic ionic properties. Circ Res. 2002;90: E73-E87.
16. Hirose M, Leatmanoratn Z, Laurita KR, Carlson MD. Partial vagal denervation increases vulnerability to vagally induced atrial fibrillation. J Cardiovasc Electrophysiol. 2002;13:1272-1279. (Pubitemid 36042727)
17. Oliveira M, da Silva MN, Timoteo AT, Feliciano J, Sousa L, Santos S, Silva-Carvalho L, Ferreira R. Inducibility of atrial fibrillation during electrophysiologic evaluation is associated with increased dispersion of atrial refractoriness. Int J Cardiol. 2009;136:130-135.
18. Hoover DB, Isaacs ER, Jacques F, Hoard JL, Page P, Armour JA. Localization of multiple neurotransmitters in surgically derived specimens of human atrial ganglia. Neuroscience. 2009;164:1170-1179.
19. Scanavacca M, Pisani CF, Hachul D, Lara S, Hardy C, Darrieux F, Trombetta I, Negrao CE, Sosa E. Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation. Circulation. 2006;114:876-885. (Pubitemid 44337130)
20. Katritsis D, Giazitzoglou E, Sougiannis D, Goumas N, Paxinos G, Camm AJ. Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation. Am J Cardiol. 2008;102:330-334.
21. Katritsis DG, Giazitzoglou E, Zografos T, Pokushalov E, Po SS, Camm AJ. Rapid pulmonary vein isolation combined with autonomic ganglia modification: a randomized study. Heart Rhythm. 2011;8: 672-678.
22. Pachon JC, Pachon EI, Lobo TJ, Pachon MZ, Vargas RN, Jatene AD. "Cardioneuroablation": new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace. 2005;7:1-13.